A detailed history of Pacer Advisors, Inc. transactions in Sanofi stock. As of the latest transaction made, Pacer Advisors, Inc. holds 822,209 shares of SNY stock, worth $39.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
822,209
Previous 784,319 4.83%
Holding current value
$39.7 Million
Previous $38.1 Million 24.58%
% of portfolio
0.11%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$48.54 - $58.53 $1.84 Million - $2.22 Million
37,890 Added 4.83%
822,209 $47.4 Million
Q2 2024

Aug 13, 2024

BUY
$45.39 - $50.36 $1.1 Million - $1.22 Million
24,257 Added 3.19%
784,319 $38.1 Million
Q1 2024

May 10, 2024

BUY
$45.75 - $52.48 $418,795 - $480,401
9,154 Added 1.22%
760,062 $36.9 Million
Q4 2023

Jan 16, 2024

BUY
$43.13 - $54.79 $3.95 Million - $5.02 Million
91,554 Added 13.89%
750,908 $37.3 Million
Q3 2023

Nov 13, 2023

BUY
$50.95 - $55.2 $788,909 - $854,716
15,484 Added 2.4%
659,354 $35.4 Million
Q2 2023

Jul 12, 2023

SELL
$50.45 - $57.18 $1.05 Million - $1.19 Million
-20,849 Reduced 3.14%
643,870 $34.7 Million
Q1 2023

May 02, 2023

BUY
$45.86 - $54.45 $9.19 Million - $10.9 Million
200,429 Added 43.17%
664,719 $36.2 Million
Q4 2022

Feb 06, 2023

BUY
$38.86 - $48.55 $6.08 Million - $7.59 Million
156,430 Added 50.81%
464,290 $22.5 Million
Q3 2022

Oct 18, 2022

BUY
$37.22 - $100.5 $2.71 Million - $7.32 Million
72,792 Added 30.97%
307,860 $11.7 Million
Q2 2022

Aug 12, 2022

BUY
$48.99 - $57.46 $6.24 Million - $7.31 Million
127,292 Added 118.11%
235,068 $11.8 Million
Q1 2022

Apr 05, 2022

BUY
$48.48 - $53.65 $512,191 - $566,812
10,565 Added 10.87%
107,776 $5.53 Million
Q4 2021

Feb 03, 2022

BUY
$47.07 - $52.35 $114,380 - $127,210
2,430 Added 2.56%
97,211 $4.87 Million
Q3 2021

Oct 15, 2021

SELL
$47.89 - $53.12 $100,712 - $111,711
-2,103 Reduced 2.17%
94,781 $4.57 Million
Q2 2021

Jul 21, 2021

BUY
$49.36 - $54.25 $285,646 - $313,944
5,787 Added 6.35%
96,884 $5.1 Million
Q1 2021

Apr 05, 2021

SELL
$45.46 - $50.51 $290,262 - $322,506
-6,385 Reduced 6.55%
91,097 $4.51 Million
Q4 2020

Jan 20, 2021

BUY
$45.3 - $51.62 $3.23 Million - $3.68 Million
71,329 Added 272.74%
97,482 $4.74 Million
Q3 2020

Oct 19, 2020

BUY
$49.47 - $53.77 $1.19 Million - $1.29 Million
23,997 Added 1113.03%
26,153 $1.31 Million
Q2 2020

Jul 29, 2020

BUY
$42.91 - $52.5 $92,513 - $113,190
2,156 New
2,156 $110,000
Q1 2020

Apr 23, 2020

SELL
$38.02 - $51.66 $3.2 Million - $4.35 Million
-84,201 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$44.25 - $50.86 $496,042 - $570,140
11,210 Added 15.36%
84,201 $4.23 Million
Q3 2019

Oct 10, 2019

SELL
$40.34 - $46.64 $70,998 - $82,086
-1,760 Reduced 2.35%
72,991 $3.38 Million
Q2 2019

Aug 12, 2019

SELL
$40.43 - $44.3 $3.99 Million - $4.37 Million
-98,750 Reduced 56.92%
74,751 $3.23 Million
Q1 2019

Apr 10, 2019

BUY
$40.83 - $45.43 $3.54 Million - $3.94 Million
86,738 Added 99.97%
173,501 $7.68 Million
Q4 2018

Feb 13, 2019

SELL
$41.48 - $45.59 $4.49 Million - $4.93 Million
-108,126 Reduced 55.48%
86,763 $3.77 Million
Q3 2018

Nov 14, 2018

BUY
$40.0 - $44.84 $211,320 - $236,889
5,283 Added 2.79%
194,889 $8.71 Million
Q2 2018

Aug 14, 2018

BUY
$37.63 - $41.22 $4.01 Million - $4.39 Million
106,542 Added 128.26%
189,606 $7.59 Million
Q1 2018

May 14, 2018

SELL
$38.98 - $45.76 $507,948 - $596,298
-13,031 Reduced 13.56%
83,064 $3.33 Million
Q4 2017

Feb 14, 2018

BUY
$42.86 - $50.61 $1.34 Million - $1.58 Million
31,243 Added 48.18%
96,095 $4.13 Million
Q3 2017

Nov 08, 2017

BUY
$47.04 - $50.34 $3.05 Million - $3.26 Million
64,852
64,852 $3.23 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.